T
think
http://www.lef.org/protocols/prtcl-108.shtml#alternative
Integrated and Alternative Prevention
Because of the anatomical nature of valvular disease, prevention may be the best approach to avoid this disorder. For example, there is evidence that the deposition of apolipoprotein A, B, and E (protein variations of the LDL cholesterol) on the aortic valve creates a binding site for calcium. Aortic valve stenosis is often described as a calcification process. Fibrinogen may also contribute to this process by depositing on aortic valves, further adding to deposit buildup by binding with calcium deposits already present on valves. Studies also implicate a chronic inflammatory process that promotes calcium infiltration into the aortic valve.
Preventing or curbing the progression of aortic-valve disease may involve lowering homocysteine, fibrinogen, and apolipoproteins A, B, and E in the blood. Consider regular blood tests to guard against hypercalcemia (too much calcium in the blood) and supplementing with magnesium (500 elemental mg a day) to possibly inhibit excess calcification of the aortic valve. Supplementing with 10 mg a day of vitamin K1 may be especially effective in preventing aortic valve calcification. Long-term anti-inflammatory therapy with nonsteroidal anti-inflammatory drugs (aspirin, ibuprofen, or prescription drugs) may be considered under the supervision of a physician. Nutrients that safely inhibit many chronic inflammatory reactions include fish oil, borage oil, curcumin, and ginger. (See the Fibrinogen, Homocysteine, and Atherosclerosis protocols for suggestions on lowering homocysteine, fibrinogen, and apolipoprotein levels.)
Since narrowed and/or leaky heart valves keep blood from being efficiently pumped, and thus place a strain on the heart muscle, we suggest you follow the Congestive Heart Failure and Cardiomyopathy protocol. The nutrients in this protocol will help strengthen the contractility of the heart muscle, but will do nothing to alleviate or correct the underlying anatomical valvular defect.
Integrated and Alternative Prevention
Because of the anatomical nature of valvular disease, prevention may be the best approach to avoid this disorder. For example, there is evidence that the deposition of apolipoprotein A, B, and E (protein variations of the LDL cholesterol) on the aortic valve creates a binding site for calcium. Aortic valve stenosis is often described as a calcification process. Fibrinogen may also contribute to this process by depositing on aortic valves, further adding to deposit buildup by binding with calcium deposits already present on valves. Studies also implicate a chronic inflammatory process that promotes calcium infiltration into the aortic valve.
Preventing or curbing the progression of aortic-valve disease may involve lowering homocysteine, fibrinogen, and apolipoproteins A, B, and E in the blood. Consider regular blood tests to guard against hypercalcemia (too much calcium in the blood) and supplementing with magnesium (500 elemental mg a day) to possibly inhibit excess calcification of the aortic valve. Supplementing with 10 mg a day of vitamin K1 may be especially effective in preventing aortic valve calcification. Long-term anti-inflammatory therapy with nonsteroidal anti-inflammatory drugs (aspirin, ibuprofen, or prescription drugs) may be considered under the supervision of a physician. Nutrients that safely inhibit many chronic inflammatory reactions include fish oil, borage oil, curcumin, and ginger. (See the Fibrinogen, Homocysteine, and Atherosclerosis protocols for suggestions on lowering homocysteine, fibrinogen, and apolipoprotein levels.)
Since narrowed and/or leaky heart valves keep blood from being efficiently pumped, and thus place a strain on the heart muscle, we suggest you follow the Congestive Heart Failure and Cardiomyopathy protocol. The nutrients in this protocol will help strengthen the contractility of the heart muscle, but will do nothing to alleviate or correct the underlying anatomical valvular defect.